The International Association for the Study of Lung Cancer (IASLC) invites you to become a valued commercial supporter of the 2027 Targeted Therapies of Lung Cancer (TTLC) Conference, taking place February 17–20, 2027, in Huntington Beach, California.

Recognized as the premier global forum for precision medicine in lung cancer, TTLC brings together more than 1,000 international experts—including leading investigators, translational scientists, fellows, and industry leaders—to present and discuss the latest advances in targeted therapies, early-phase clinical trials, predictive biomarkers, and emerging scientific and clinical data.

Supporting TTLC 2027 provides a unique opportunity to connect with key decision-makers and thought leaders, showcase your organization's innovations, and align your brand with a global community dedicated to advancing lung cancer research and patient care. We invite you to explore the sponsorship and engagement opportunities available and discover how your organization can help shape the future of precision medicine in lung cancer.

The order form opens Wednesday, July 22, 2026 at 12:00 PM MDT. 

Contact Us

For information regarding TTLC Commercial Support Opportunities, please contact corporaterelations@iaslc.org.